Susan Hasty, Publisher
Table of Contents . . . July 26th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Gene Therapy Week | Other Publications
Cancer Therapy - DNA methylation shows promise for treating advanced prostate cancer
Drug Development - The novel Escherichia coli YeiK gene product is a gene therapy candidate
Lung Cancer - New data suggest FUS1 therapy may play role in preventing onset of lung cancer
Pancreatic Cancer - Ad/TRAIL-F/RGD may be potent therapeutic agent for pancreatic cancer
Bronchoalveolar Carcinoma - Phase II trial of GVAX lung cancer vaccine begins
Cancer Risk - Rapid rise in PSA level sign of aggressive prostate cancer
Clinical Genetics - Genetic profiling has advanced our knowledge of non-small cell lung cancer
Drug Resistance - Bcl-2 antisense agent G3139 invokes a response to refractory multiple myeloma
Immunology - CD40 ligand gene therapy halts Th2-mediated tumor escape
Neuroblastoma - Amplifications in chromosome arm 1p identified
Oncology - Proteo-genomics system identifies malignant antibody targets
Personnel - Gerhard Baumgartner joins Chemophase maker's scientific advisory board
Prostate Cancer - Novel candidate oncogene identified
Restructuring - Drug-discovery company to focus resources on expanding clinical pipeline
Stem Cell Transplantation - Deletion of chromosome band 13q14 prognostic factor in multiple myeloma with SCT
Stem-Cell Research - L3MBTL implications for pathogenesis of myeloid malignancy 20q deletions
Stem-Cell Research - Type I HBEC immortalization may be early step in breast cancer subset initiation
Vector Development - Human serum albumin nanoparticles deliver antisense nucleotides to tumor cells
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.